WO2009144624A1 - Dispositif d'apport de médicament commandé - Google Patents
Dispositif d'apport de médicament commandé Download PDFInfo
- Publication number
- WO2009144624A1 WO2009144624A1 PCT/IB2009/052095 IB2009052095W WO2009144624A1 WO 2009144624 A1 WO2009144624 A1 WO 2009144624A1 IB 2009052095 W IB2009052095 W IB 2009052095W WO 2009144624 A1 WO2009144624 A1 WO 2009144624A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- drug delivery
- reservoir
- opening
- drum
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title claims abstract description 29
- 239000000599 controlled substance Substances 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 91
- 229940079593 drug Drugs 0.000 claims abstract description 87
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002699 waste material Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 2
- 239000002195 soluble material Substances 0.000 claims description 2
- 230000007246 mechanism Effects 0.000 description 12
- 239000012530 fluid Substances 0.000 description 9
- 239000008247 solid mixture Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 108010014172 Factor V Proteins 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
Definitions
- This invention relates to a device for controlled drug delivery, the device comprising multiple drug reservoirs for comprising a drug, releasing means for releasing the drug from the drug reservoir and a controller for controlling the drug release.
- a self-powered implanted device comprising a store of medicine in powdered, liquid or other dispensable form.
- the medicine is gradually discharged incrementally over a substantially long period of time.
- the medicine is comprised in capsules situated in cavities at the circumference of a wheel. Each cavity has an associated piston member for pushing the capsule out of the cavity. One capsule a day is released in this way. Due to the complex mechanical structure of this device, the amount of drug that can be stored in it is very small relative to the size of the device.
- US patent 5,660,846 discloses an implantable device for the automatic delivery of an active ingredient according to an adjustable delivery profile.
- the device includes a reservoir for storing the active ingredient in a solid composition.
- An actuator moves the solid composition from the reservoir to a transit area.
- the solid composition exits the housing at the transit area.
- a controller acts on the actuator to adjust movement of the solid composition out of the housing according to the delivery profile.
- the solid composition is a cable-like carrier comprising a drug and rolled over a pin.
- the cable is slowly rolled out for moving the composition out of the housing.
- the rolling out of the carrier must be performed continuously, because otherwise water from the environment will diffuse into the device.
- the drug and the carrier are carefully selected and compounded in such a proportion that the drug is immediately released from the carrier upon contact with a liquid. Selecting and compounding of the drug-carrier combination is therefore a complex task.
- this object is achieved by providing a device for controlled drug delivery, the device comprising a rotatable drum, multiple drug reservoirs, a housing enclosing the drum, rotating means and a controller for controlling the rotating means.
- the drug reservoirs are arranged along a helical track at an outer surface of the rotatable drum.
- the housing comprises an opening for enabling release of a drug from one of the drug reservoirs to a surrounding tissue.
- the rotating means are arranged for rotating the drum in order to bring a drug reservoir in front of the opening. Releasing means are provided for releasing the drug from the drug reservoir in front of the opening.
- the drug delivery device saves space by bending the plane with the drug reservoirs in a cylindrical shape (at least in the shape of a rotatable drum). In theory this would save a factor ⁇ (3,14159).
- the invention thus makes it possible to put more drugs in a smaller device. For implantable drug delivery devices this is very advantageous.
- the arrangement of drug reservoirs along the helical track makes it very easy to put the reservoirs in front of the opening in the housing, one by one, by just rotating the drum.
- the controller controls the rotating means, and therewith the time scheme for the drug delivery.
- the rotating means and/or the controller are at least partially situated inside the rotatable drum in order to further reduce the size of the device relative to the amount of drugs it can comprise.
- the releasing means may be realized in many different ways. Some exemplary embodiments are described below in the detailed description of the invention.
- Fig. 1 schematically shows an embodiment of the drug delivery device according to the invention
- Fig. 2 shows a further drug delivery device according to the invention
- Fig. 3 shows a releasing mechanism comprising a strip for closing the drug reservoirs
- Fig. 4 shows a releasing mechanism comprising a cutting part
- Fig. 5 shows a releasing mechanism based on a narrowing of the available space for the drug reservoir
- Fig. 6 shows the releasing mechanism of Fig. 5 from another point of view.
- Fig. 1 schematically shows an embodiment of the drug delivery device 10 according to the invention.
- the device 10 comprises a housing 13 with an opening 14. Inside the housing 13, a rotatable drum 11 is located.
- the rotatable drum 11 is preferably cylindrical, but other shapes may also be used.
- a plurality of drug reservoirs 12 is arranged.
- the reservoirs 12 are arranged along a helical track.
- One of the drug reservoirs 12 is situated in front of the opening 14 in the housing 13.
- a releasing mechanism (not shown in Fig. 1) close to the opening, releases the drug from the drug reservoir 12.
- the actuator 15 rotates the drum 11, such that the empty reservoir 12 moves away from the opening 14 and a drug filled reservoir 12 moves in front of the opening 14.
- the releasing means then releases the drug from the drug filled reservoir 12. If the releasing of the drug results in any waste material, e.g., (part of) an empty drug reservoir 12, then the waste material is preferably collected in a waste collection space 17 inside the device.
- the actuator 15 may be motor-driven, electro- magnetic based, osmotic pressure based, etc.
- Electronic circuitry 16 is provided to rotate the drum 11 according to a predetermined time schedule. If the electronic circuitry 16 also comprises a transmitter/receiver for communicating with external control equipment, the device 10 may be programmed and reprogrammed after it has been implanted in a patient. The device 10 may further comprise one or more sensors for monitoring some biological parameters of the tissue in which the device 10 has been implanted or for monitoring the functioning of the device 10. The sensor output may, e.g., be used for triggering drug delivery or for adapting the drug release schedule. Such adaptations may be performed by the electronic circuitry 16 or by a user after receiving the obtained parameters via a transmitter/receiver.
- the electronic circuitry 16 and the actuator 15 are powered by a power source (e.g. a battery). Preferably, the battery, the electronic circuitry 16 and the actuator 15 are partially or fully situated inside the drum 11 for further reducing the size of the device 10.
- a power source e.g. a battery
- the device 10 delivers medication to the surrounding tissue or fluid.
- the surrounding fluids into which the substances are released can be, for example, environments such as intravenous infusions, interstitial fluids and stomach and intestinal juices.
- the fluid into which the drug is dissolved is provided by the device 10 itself (e.g. stored in an extra reservoir), which with the help of a catheter may be brought to the desired treatment location.
- the drum 11 with the drug may be suspended in a non-solvent (e.g. oil), which protects the drug from the surrounding watery environment.
- Fig. 2 shows a further drug delivery 10 device according to the invention.
- this drug delivery device 10 comprises a compressible carrier fluid reservoir 21 for compensating for the pressure difference caused by releasing the drug from the device 10. If this pressure difference is not compensated for, water from the device's surrounding environment may enter the housing 13 and deteriorate the functioning of the device 10.
- the carrier fluid reservoir 21 may comprise a reservoir fill port 22 for filling the carrier fluid reservoir 21 with additional fluid in order to minimize the pressure difference between the device 10 and its environment.
- the device 10 of Fig. 2 further comprises a catheter 23 for transportation of the released drug from the opening 14 in the housing 13 to the environment of the device 10.
- releasing the drug from the drug reservoir 12 may be performed by a variety of releasing mechanisms.
- the fluid reservoir 21 may provide a fluid for dissolving the material of the drug reservoir 12 in order to release the drug from the reservoir 12.
- Fig. 3 shows a releasing mechanism comprising a strip 31 for closing the drug reservoirs 12.
- the reservoir 12 is a medicine bag, which is protected by a strip 31.
- the drug is released by pulling off the strip 31.
- the pulled-off strip 31 may be collected in the waste collecting space 17.
- the pulling off is performed mechanically and is preferably a direct result of the rotating of the drum 11.
- a separate actuator performs the pulling. This actuator may also be controlled by the electronic circuitry 16.
- Fig. 4 shows a releasing mechanism comprising a cutting part 41.
- This embodiment is based on "tea-bag- like"- formed drugs bags 42, made of water soluble material. Inside of the device, between the drum 11 and the housing, oil is present that protects the bags 42 against water. Once cut loose by the cutting part 41 the drug bags 42 will 'transport' to the human body tissue where water causes the bags 12 to degrade. After this degradation the drug is finally active and providing a therapeutic effect.
- Fig. 5 shows a releasing mechanism based on a narrowing 51 of the available space for the drug reservoir 12 and Fig. 6 shows the releasing mechanism of Fig. 5 from another point of view.
- This embodiment is based on a drug bag 12 with a drug 61, which is pressed into a pyramidal form or another form with sharp corners.
- a small region 51 of the envelope of the device is made flat so that the drum 11 will squeeze the drug 61 against the wall of the reservoir 12. Since the drug 61 itself has sharp edges it will break the shell of the reservoir 12 and will be released.
- other sharp objects (attached to the shell or loose) might be used for cutting through the shell instead of the drug 61 itself.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
L'invention concerne un dispositif (10) d'apport de médicament commandé, ce dispositif comprenant un tambour rotatif (11), de multiples réservoirs de médicament (12), un boîtier (13) entourant le tambour (11), un moyen de rotation (15) et un contrôleur (16) permettant de commander le moyen de rotation. Les réservoirs de médicament (12) sont placés le long d'un tracé hélicoïdal à une surface extérieure du tambour rotatif (11). Le boîtier (13) comprend une ouverture (14) pour permettre de libérer un médicament d'un des réservoirs de médicament (12) sur un tissu environnant. Le moyen de rotation (15) est agencé de manière à faire tourner le tambour (11) afin de placer un réservoir de médicament (12) en face de l'ouverture (14). Des moyens de libération sont prévus pour libérer les médicaments du réservoir de médicament (12) en face de l'ouverture (14)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08157040 | 2008-05-28 | ||
EP08157040.0 | 2008-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009144624A1 true WO2009144624A1 (fr) | 2009-12-03 |
Family
ID=40974532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2009/052095 WO2009144624A1 (fr) | 2008-05-28 | 2009-05-20 | Dispositif d'apport de médicament commandé |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009144624A1 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4576591A (en) * | 1983-07-06 | 1986-03-18 | Ivy-Gene Co., Inc. | Medicament implant applicator |
WO2002089767A1 (fr) * | 2001-05-03 | 2002-11-14 | Massachusetts Eye And Ear Infirmary | Dispositif d'administration de medicament implantable et utilisation associee |
WO2003024518A2 (fr) * | 2001-09-14 | 2003-03-27 | The Procter & Gamble Company | Microstructures destinees a distribuer une composition par voie cutanee dans la peau au moyen de structures rotatives |
-
2009
- 2009-05-20 WO PCT/IB2009/052095 patent/WO2009144624A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4576591A (en) * | 1983-07-06 | 1986-03-18 | Ivy-Gene Co., Inc. | Medicament implant applicator |
WO2002089767A1 (fr) * | 2001-05-03 | 2002-11-14 | Massachusetts Eye And Ear Infirmary | Dispositif d'administration de medicament implantable et utilisation associee |
WO2003024518A2 (fr) * | 2001-09-14 | 2003-03-27 | The Procter & Gamble Company | Microstructures destinees a distribuer une composition par voie cutanee dans la peau au moyen de structures rotatives |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11833328B2 (en) | Treatment system with automated cannula and sensor inserter, fluid delivery device, and drive mechanism for use therewith | |
US20220211938A1 (en) | Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith | |
EP2086611B1 (fr) | Dispositif d'administration de médicament, capsule et système d'administration de médicament ou de diagnostic in vivo | |
JP5653217B2 (ja) | 外部薬剤ポンプ | |
ES2324341T3 (es) | Dosificador para dispositivo de infusion de pacientes. | |
KR101070203B1 (ko) | 의료용 소형 자동 주입 및 샘플 채취 장치 | |
US10159785B2 (en) | Motion activated septum puncturing drug delivery device | |
US20040015131A1 (en) | Flow restriction system and method for patient infusion device | |
KR20190104310A (ko) | 분배가능한 물질의 전달을 위한 전자기계식 섭취가능한 디바이스 | |
US20180271752A1 (en) | Drug delivery capsules with external intelligence | |
CN107405446A (zh) | 流体输送和输注装置及其使用方法 | |
EP2595672B1 (fr) | Système pour l'administration contrôlée d'une substance depuis un dispositif de perfusion implanté dans le corps humain | |
JP2018504942A (ja) | 滅菌組立式液体薬剤投与量制御及び送達デバイス | |
WO2005077450A2 (fr) | Systeme d'administration intravasculaire d'agents therapeutiques | |
EP2464413B1 (fr) | Reservoir de medicament pour dispositif d'administration de medicament | |
CN101010115A (zh) | 用于输送至少一种药物的电子控制药丸和系统 | |
JP2003517864A (ja) | 消化管の明確な位置に物質を放出するための経口摂取可能装置 | |
JP2014528332A (ja) | 固体薬物の送達装置、製剤および使用の方法 | |
US10967122B2 (en) | Subcutaneous drug delivery device with manual activation and deactivation of drug release | |
WO2009144624A1 (fr) | Dispositif d'apport de médicament commandé | |
PL187304B1 (pl) | Wstępnie ładowane urządzenie do wszczepiania | |
CN116474207A (zh) | 带有集成传感器的移动式输注泵装置 | |
CN115720524A (zh) | 用于通过注射进行的自动控制肠胃外给药的胶囊、装置、系统和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09754251 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09754251 Country of ref document: EP Kind code of ref document: A1 |